NSE - Delayed Quote INR

Wanbury Limited (WANBURY.NS)

Compare

259.22

+5.14

+(2.02%)

At close: 3:29:35 PM GMT+5:30

Key Events

Advanced Chart

Loading Chart for WANBURY.NS

Previous Close 254.08
Open 255.75
Bid --
Ask --
Day's Range 253.00 - 266.00
52 Week Range 131.20 - 323.53
Volume 66,877
Avg. Volume 142,471
Market Cap (intraday) 8.557B
Beta (5Y Monthly) 0.44
PE Ratio (TTM) 19.80
EPS (TTM) 13.09
Earnings Date May 14, 2025 - May 19, 2025
Forward Dividend & Yield --
Ex-Dividend Date Jul 29, 2010
1y Target Est --

Wanbury Limited manufactures and sells formulations and active pharmaceutical ingredients (API) in India and internationally. The company offers formulations for gynecology, orthopedics, hematinic, anti-diabetic, nutraceuticals, gastro intestinal, stroke surgery, antibiotics, cough and cold solutions, anti-inflammatory, analgesics, and general practitioner. It also provides API products for anti-diabetic, anti-analgesic, anti-depressant, anti-histaminic, anti-inflammatory, anti-arthritis, anti-thrombotic, anti-epileptic, and anti-hypertensive therapeutic areas. The company was formerly known as Pearl Organics Limited and changed its name to Wanbury Limited in 2004. Wanbury Limited was incorporated in 1988 and is headquartered in Navi Mumbai, India.

www.wanbury.com

1,491

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Drug Manufacturers - Specialty & Generic

Industry

Trailing total returns as of 4/16/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

WANBURY.NS

10.98%

S&P BSE SENSEX (^BSESN)

1.40%

1-Year Return

WANBURY.NS

71.90%

S&P BSE SENSEX (^BSESN)

5.62%

3-Year Return

WANBURY.NS

205.14%

S&P BSE SENSEX (^BSESN)

32.06%

5-Year Return

WANBURY.NS

964.56%

S&P BSE SENSEX (^BSESN)

151.76%

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

WANBURY.NS

Wanbury Limited

259.22

+2.02%

Mkt Cap INR 8.557B